SITERA Pharmaceuticals is a preclinical-stage biotech developing small molecule therapeutics that target Mitochondria-Associated Membranes (MAMs), a critical hub for neuronal signaling and metabolism.

Our mission: deliver innovative therapies for patients with rare and prevalent neurodegenerative diseases who have run out of options.

Leveraging a proprietary platform combining cutting-edge chemistry and biology, we design potent, selective, and safe CNS therapeutics, addressing some of the most challenging unmet needs in neurology.

SITERA Pharma

Org chart

Teams

Offices

SITERA Pharma

Org chart

Teams

Offices

Related companies